SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 8.47% growth in the revenue at Rs. 9909.10 millions for the quarter ended December 2025 as compared to Rs. 9135.10 millions during the year-ago period.A slim rise of 14.63% was recorded in the Net profit for the quarter ended December 2025 to Rs. 1792.70  millions  From Rs. 1563.90 millions.Operating profit surged to 2863.90 millions from the corresponding previous quarter of 2525.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 9909.10 9135.10 8.47 30534.60 28215.80 8.22 37229.20 32986.40 12.86
Other Income 168.90 71.60 135.89 450.40 212.10 112.35 347.40 346.80 0.17
PBIDT 2863.90 2525.60 13.39 9060.20 8081.70 12.11 10526.80 9141.00 15.16
Interest 15.90 18.50 -14.05 32.60 81.90 -60.20 91.20 405.20 -77.49
PBDT 2848.00 2507.10 13.60 9027.60 7999.80 12.85 10435.60 8735.80 19.46
Depreciation 436.20 411.80 5.93 1281.30 1220.40 4.99 1664.50 1352.40 23.08
PBT 2411.80 2095.30 15.11 7746.30 6779.40 14.26 8771.10 7383.40 18.79
TAX 619.10 531.40 16.50 1970.70 1752.00 12.48 2245.70 1949.80 15.18
Deferred Tax 38.30 96.90 -60.47 108.10 271.00 -60.11 328.80 494.90 -33.56
PAT 1792.70 1563.90 14.63 5775.60 5027.40 14.88 6525.40 5433.60 20.09
Equity 156.70 155.50 0.77 156.70 155.50 0.77 155.70 155.20 0.32
PBIDTM(%) 28.90 27.65 4.54 29.67 28.64 3.59 28.28 27.71 2.04

JB Chem & Pharma Share Price

1998.65 -5.10 (-0.25%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×